Patient Initiated Side Effects Reporting System in their Vernacular Language: A Cross Sectional Analysis of Feasibility and Acceptability in Our Scenario

    Published on:December 2020
    Journal of Young Pharmacists, 2020; 12(4):370-372
    Original Article | doi:10.5530/jyp.2020.12.94

    Krishnan Vengadaragava Chary1,*, Karthik VP2

    1Department of Pharmacology, Panimalar Medical College Hospital and Research Institute, Chennai, Tamil Nadu, INDIA.

    2Department of Pharmacology, Sri Ramachandra Medical College, Porur, Chennai, Tamil Nadu, INDIA.


    Objectives: To determine the acceptability of Patient initiated side effects reporting system in their vernacular language. Methods: All the hundred participants were using simple non-probability sampling; participants were given red form and blue form 9 Central drug standard and control suspected adverse effects form for physicians and patients respectively), placed them comfortably and asked to compare and their answers were coded when there were ready to convey the answers. All the questions were closed ended with prior testing with Cronbach alpha value of 0.75 to find suitability, both sheets were give and time allotted for them to get acquaintainted and then questions were put forth. Results: Nearly 65 subjects were aware that even minor side effects should be reported in blue form by themselves while 35% percentage was not familiar with it. Another significant finding about 66% people was not familiar with their names or identity such as revealing it in the form. Conclusion: Having adverse drug reaction from and measures taken were laudable; however, suitability and feasibility in our Indian scenario should be improved. Population education may play a key role and appointing social pharmacist is also a key option to alleviate ground level disconnects.

    Key words: Patient initiated adverse drug reporting, Consumer side effects reporting from, Blue and red from.

    Article Download